News Muncher - category zepbound

2 days, 17 hours ago

FDA approves Zepbound: First prescription medication for obstructive sleep apnea in adults

The US Food and Drug Administration has approved the first prescription medicine for adults with moderate-to-severe obstructive sleep apnea : the weight-loss drug Zepbound. Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their sleep disorder. “This is a major step forward for patients with obstructive sleep apnea,” Dr. Sally Seymour, director of the FDA’s Division of …

Sleep Fda Adults Obstructive Sleep Apnea Zepbound Osa

3 days, 21 hours ago

FDA says knockoff versions of Lilly obesity drug must come off the market

Associated Press

WASHINGTON — Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal decision issued Thursday. With demand for GLP-1 drugs booming, compounding pharmacies and telehealth companies like Hims and Ro have jumped into the market, selling cheaper versions online. …

Drugs Drug Fda Glp Zepbound Versions Mounjaro

2 weeks, 4 days ago

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

India Today

In a study trial, pharmaceutical giant Eli Lilly's weight-loss drug Zepbound showed better results than another pharmaceutical company, Novo Nordisk's weight-loss drug Wegovy. The trial, called SURMOUNT-5, compared Zepbound to Wegovy, which is a mono GLP-1 receptor agonist in adults living with obesity without diabetes. The results showed Zepbound delivering a remarkable 47% greater relative weight loss compared to Wegovy, …

Obesity Weight Drug Wegovy Zepbound

2 weeks, 4 days ago

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

The Independent

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Obesity Weight Novo Nordisk Novo Living Well Zepbound Eli Lilly

2 weeks, 5 days ago

Zepbound tops Wegovy for weight loss in Eli Lilly study

Associated Press

Share Share Copy Link copied Email Facebook X Reddit LinkedIn Pinterest Flipboard Print Shares of Eli Lilly climbed Wednesday after the drugmaker detailed a study showing that its blockbuster weight-loss drug Zepbound helped patients shed more pounds than Wegovy from rival Novo Nordisk. Lilly said patients taking Zepbound lost about 20% of their weight on average compared to nearly 14% …

Weight Loss Drug Wegovy Zepbound Eli Lilly Lilly

2 weeks, 5 days ago

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Live Mint

In the first head-to-head test, Eli Lilly’s Zepbound obesity drug helped people lose significantly more weight than its main competitor, Novo Nordisk’s Wegovy. The details People taking Zepbound lost 20.2% of their body weight on average after 72 weeks of treatment in the Lilly- That translated into an average 50-pound loss for people who took Zepbound, while Wegovy users lost …

Weight Novo Nordisk Wegovy Novo Zepbound Lilly

3 weeks, 1 day ago

Eli Lilly and Novo Nordisk’s obesity moat just got stronger

Live Mint

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. Not only did MariTide fail to outperform Lilly’s Zepbound, but both Lilly and Novo also have next-generation medications under development, with promising data showing even more impressive weight loss results. “A 20% weight loss would have been best-in-class if …

Market Obesity Weight Drug Novo Nordisk Novo Zepbound

3 weeks, 6 days ago

Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans

Associated Press

WASHINGTON — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning. The costly proposal from the U.S. Department of Health and Human Services immediately sets the stage for a showdown between the powerful pharmaceutical industry and Robert …

Medicare Drugs Trump Obesity Coverage Kennedy Biden

$Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices$

1 month ago

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …

China Novo Nordisk Wegovy Cnn Novo

1 month ago

Drugmakers and pharmacists battle over who gets to make obesity drugs

NPR

Drugmakers and pharmacists battle over who gets to make obesity drugs toggle caption James Manning/PA Images/Getty Images Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high demand that the drugmakers have had a hard time keeping up. "Everybody knows that… injections are going to come off the shortage list eventually and patients need to …

Drugs Patients Drug Fda Novo Nordisk Npr Sponsor Message

1 month ago

Medicaid fuels US coverage of Novo, Lilly weight-loss drugs

Live Mint

* U.S. government health plans cover 52.2 million for new weight-loss drugs * An estimated 24.4 million in commercial plans have similar coverage * Fourteen state Medicaid programs cover GLP-1 drugs for obesity By Chad Terhune Nov 18 - U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available …

Health Insurance Drugs Million Reuters Medicaid Novo

1 month ago

Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?

Live Mint

Pharmaceutical companies are typically rewarded for their innovation with years of market exclusivity before cheaper generics enter the scene. That window for mass drug compounding, however, could start to close if the FDA upholds its recent determination that tirzepatide, the active ingredient in Eli Lilly’s Zepbound and Mounjaro, is no longer in short supply. If the FDA moves to restrict …

Supply Fda Novo Available Zepbound Mounjaro Eli Lilly

1 month, 1 week ago

Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people

CNN

Editor’s note: Watch “Dr. “I wanted to prove to myself that I could lose the last 10 pounds towards my goal weight naturally, just so that I wouldn’t be dependent on the medicine,” she said. “I feel like it’s my family now.” Bell has lost almost 100 pounds after taking Ozempic and joining a fitness studio. Method: Wegovy, diet changes, …

Life Changes California Weight Ozempic Cnn Stop

1 month, 1 week ago

Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people

CNN

Editor’s note: Watch “Dr. “I wanted to prove to myself that I could lose the last 10 pounds towards my goal weight naturally, just so that I wouldn’t be dependent on the medicine,” she said. “I feel like it’s my family now.” Bell has lost almost 100 pounds after taking Ozempic and joining a fitness studio. Method: Wegovy, diet changes, …

Diet Loss Drugs Life Changes California Weight

1 month, 1 week ago

Could weight loss drugs fix UK’s unemployment problem?

Al Jazeera

US pharmaceuticals group Eli Lilly is to conduct trials of its weight-loss drugs Mounjaro and Zepbound in the UK. The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes Streeting announced last month that US drug manufacturer Eli Lilly will begin a five-year trial in Greater Manchester to …

Health Weight Loss Loss Drugs Unemployment Work Weight

1 month, 2 weeks ago

Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs

LA Times

Shauna Bookless never imagined she’d become her own pharmacist. “I’m playing doctor,” Bookless said, describing her foray into the world of do-it-yourself GLP-1 medication, injections developed to control diabetes and now also used for weight loss. Some patients, with or without the help of doctors, are experimenting with “microdosing” weight loss drugs — using smaller-than-recommended amounts — in order to …

Weight Loss Drugs Bhatia Patients Weight Ozempic Doctor

1 month, 2 weeks ago

Big Pharma’s obesity bonanza faces new tests

Live Mint

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Obesity Investors Drug Novo Nordisk Wegovy Novo Glp

2 months, 2 weeks ago

Lilly weight-loss drug copycats dealt blow as shortage ends

LA Times

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S. Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the U.S., threatening to upend the many knockoffs that became popular when patients couldn’t find the brand-name medicines. The Food and Drug …

Drugs Drug Fda Zepbound Mounjaro Lilly Shortage Ends

3 months, 2 weeks ago

162 US deaths linked to Ozempic and similar weight loss drugs

Daily Mail

Weight loss shots like Ozempic have been linked to 162 deaths in the US, DailyMail.com can reveal. The system has recorded 62,000 reactions to weight loss drugs containing semaglutide and tirzepatide like Ozempic and Mounjaro in the US since 2018. Juanita Gantt was found by her husband Robert unconscious one day in October 2023 and rushed her to the hospital …

Weight Loss Loss Drugs Deaths Patients Weight Ozempic

4 months, 1 week ago

Cheaper alternatives to Ozempic are flooding the weight-loss market. Are they safe?

LA Times

As weight-loss hopefuls struggle to get name-brand Ozempic, many are turning to a booming, less regulated secondary market for compounded versions of the blockbuster drug. “We urge patients to be vigilant,” said a spokesperson for the FDA, which has issued several alerts and letters recently about concerns related to compounded semaglutide. — Food and Drug Administration The agency has issued …

Market Drugs Online Patients Pharmacies Company Ozempic

4 months, 2 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Weight Loss Market Company Billion Novo Nordisk Wegovy Novo

4 months, 2 weeks ago

Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter

Associated Press

INDIANAPOLIS — Eli Lilly blew past second-quarter expectations with the diabetes treatment Mounjaro and its weight loss counterpart Zepbound funneling more than $4 billion in sales to the drugmaker. Lilly also hiked its forecast for the year well beyond Wall Street expectations as newer drugs like Zepbound built momentum. Leerink Partners analyst David Risinger noted that insurance coverage of Zepbound …

Billion Quarter Zepbound Mounjaro Eli Lilly Lilly

5 months, 1 week ago

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Firstpost

Eli Lilly, the pharmaceutical company, has received the first approval for the sale of its blockbuster drug Tirzepatide in India. Here’s what we know about this ‘game-changing’ medication A box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly is seen at Rock Canyon Pharmacy in Provo, Utah. Last week, the apex drug regulator’s, …

India Weight Loss Loss Drugs Diabetes Weight Drug

6 months ago

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea

The Independent

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

Sleep Obesity Sleep Apnea Drug Treat Tirzepatide Apnea

Filters

Articles for Zepbound

FDA approves Zepbound: First prescription medication for obstructive sleep apnea in adults

FDA says knockoff versions of Lilly obesity drug must come off the market

Eli Lilly new trial is all about the battle to be best weight-loss drug zepbound and wegovy

Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says

Zepbound tops Wegovy for weight loss in Eli Lilly study

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

Eli Lilly and Novo Nordisk’s obesity moat just got stronger

Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Drugmakers and pharmacists battle over who gets to make obesity drugs

Medicaid fuels US coverage of Novo, Lilly weight-loss drugs

Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?

Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people

Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people

Could weight loss drugs fix UK’s unemployment problem?

Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs

Big Pharma’s obesity bonanza faces new tests

Lilly weight-loss drug copycats dealt blow as shortage ends

162 US deaths linked to Ozempic and similar weight loss drugs

Cheaper alternatives to Ozempic are flooding the weight-loss market. Are they safe?

Eli Lilly is gaining on Novo Nordisk in the obesity race

Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter

India one step closer to approving weight-loss drug tirzepatide: What is it? How does it work?

Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea